.
Pharmaceutical Policy and Management
Study Course Description
Course Description Statuss:Approved
Course Description Version:4.00
Study Course Accepted:02.02.2024 12:29:44
| Study Course Information | |||||||||
| Course Code: | VVDG_008 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Basic Sciences of Medicine, including Pharmacy; Social Pharmacy | Target Audience: | Health Management | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Daiga Behmane | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Faculty of Social Sciences | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Dzirciema street 16, Rīga, szf rsu[pnkts]lv | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 6 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 12 | ||||
| Classes (count) | 6 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 12 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | None required. | ||||||||
| Objective: | The student gains knowledge about pharmaceutical policy and regulation of pharmaceutical systems in the European Union, aspects of the pharmaceutical market, its regulation, globalisation trends, the role of the government in the regulation of the pharmaceutical market. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Pharmaceutical market: characteristics, globalisation trends, market segments, market operators | Lectures | 1.00 | auditorium | |||||
| 2 | Pharmaceutical market analysis | Classes | 1.00 | auditorium | |||||
| 3 | Characteristics and regulation of the pharmaceutical industry | Lectures | 1.00 | auditorium | |||||
| 4 | Analysis of laws and regulations governing pharmacy | Classes | 1.00 | auditorium | |||||
| 5 | National medicinal product policy and principles for the development thereof | Lectures | 1.00 | auditorium | |||||
| 6 | Comparative analysis and evaluation of medicinal product policy | Classes | 1.00 | auditorium | |||||
| 7 | Objectives, tasks, structural principles of reimbursement systems | Lectures | 1.00 | auditorium | |||||
| 8 | Analysis of reimbursement systems | Classes | 1.00 | auditorium | |||||
| 9 | Medicinal product cost control measures, supply and demand aspects, price formation in the medicinal product market | Lectures | 1.00 | auditorium | |||||
| 10 | Comparative analysis of the costs of medicinal products | Classes | 1.00 | auditorium | |||||
| 11 | Principles and application of economic evaluation of medicinal products | Lectures | 1.00 | auditorium | |||||
| 12 | Economic evaluation of medicinal products | Classes | 1.00 | auditorium | |||||
| Assessment | |||||||||
| Unaided Work: | Analysis of problem situations. Data analysis and evaluation. Analysis of policy documents. | ||||||||
| Assessment Criteria: | Activity during the interactive lectures. Solving situational tasks in classes. Presentation of independent work. Correct answers in the written test. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | To understand the principles of pharmaceutical policy-making and the role of the pharmaceutical system in national social security systems, the content of pharmaceutical policy. To understand the aims and objectives of pharmaceutical policy. To understand the global aspects, development trends and challenges of the pharmaceutical market and the need to balance the goals of the pharmaceutical industry and public health. To understand the regulation of the pharmaceutical industry at the European Union and national level. To understand the regulatory aspects of the pharmaceutical market and the role of the government in regulation. To understand the pricing aspects of medicinal products. To understand the factors affecting the cost of medicinal products. | ||||||||
| Skills: | To determine the aims and objectives of pharmaceutical systems. To analyse the performance of pharmaceutical systems according to their key performance indicators. To analyse the performance indicators of the pharmaceutical system. To analyse the elements of the pharmaceutical market, development trends. To compare the development of the medicinal product market in different countries. To identify the factors influencing the cost of medicinal products and how they can be limited. To define the roles and design principles of hospital medicinal product procurement systems. To define the roles and design principles of medicinal product reimbursement systems. To identify issues in pharmaceutical systems and justify them for research. To assess the performance of pharmaceutical systems against their target indicators. | ||||||||
| Competencies: | To develop the aims, objectives of pharmaceutical policy. To determine the tasks of pharmaceutical system development. To contribute to the development of laws and regulations governing the pharmaceutical system. To analyse the medicinal product market. To establish medicinal product procurement systems at the level of a medical treatment institution. To make proposals for regulating the prices of medicinal products. To make proposals for action on the factors affecting the cost of medicinal products. To participate in research projects in the pharmaceutical field. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | E.Mossialos, M.Mrazek, T.Walley „Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality, European Observatory on Health Systems and Policies, 2004 (akceptējams izdevums) | ||||||||
| 2 | Drugs and money: Prices, affordability and cost containment, 7th edition, 2003, WHO (akceptējams izdevums) | ||||||||
| Additional Reading | |||||||||
| 1 | Priority Medicines for Europe and the World update Report, 2013 | ||||||||
| Other Information Sources | |||||||||
| 1 | http://ec.europa.eu/enterprise/sectors/pharmaceuticals/ | ||||||||
| 2 | www.who.int/medicines/ | ||||||||
| 3 | http://whocc.goeg.at | ||||||||
